Current advances in platelet-rich plasma therapy for erectile dysfunction: a meta-analysis of randomized controlled trials
The Journal of Sexual Medicine · 05.01.2026 · 23 (1)
DOI: 10.1093/jsxmed/qdaf325 ↗Kurz gefasst
Metaanalyse in der Zeitschrift The Journal of Sexual Medicine, online erschienen am 25.11.2025. Verfasst von Dayan Jacob und 10 weiteren Autor:innen. Beteiligte Einrichtung: Manchester Andrology Research Collaborative (MARC), Department of Urology, Manchester, M13 9WL, United Kingdom. Hauptthemen laut MEDLINE: Platelet-Rich Plasma, Erectile Dysfunction. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben.
Abstract (Originalsprache)
Introduction
Erectile dysfunction (ED) is a prevalent condition with multifactorial etiology and significant impact on men’s quality of life. Although standard therapies—such as phosphodiesterase type 5 inhibitors, vacuum devices, and penile prostheses—offer symptomatic relief, they do not address the underlying pathophysiology. Platelet-rich plasma (PRP), an autologous concentration of platelets and growth factors, has emerged as a potential regenerative treatment that may promote neurovascular repair and restore erectile function.
Aim
To evaluate the efficacy and safety of PRP monotherapy for the treatment of erectile dysfunction through a systematic review and meta-analysis of randomized controlled trials (RCTs).
Methods
Following PRISMA guidelines, a comprehensive search of PubMed, EMBASE, Google Scholar, Cochrane Library, Scopus, and Web of Science was performed for RCTs assessing intracavernosal PRP injections in men with ED. Studies combining PRP with other regenerative therapies were excluded. Data were synthesized using a random-effects model to generate pooled standardized mean differences (SMDs) in International Index of Erectile Function (IIEF) scores at 1, 3, and 6 months. Risk of bias was assessed using the Cochrane RoB 2 tool, and certainty of evidence was evaluated using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework.
Results
Seven RCTs including 512 participants were analyzed. PRP injection volumes ranged from 5 to 10 mL across 2-4 sessions. At 1 month, pooled SMD in IIEF was 0.28 (95% CI −0.11 to 0.67, P = .16); at 3 months, it was 0.29 (95% CI −0.08 to 0.67, P < .05); and at 6 months, it was 0.36 (95% CI −0.09 to 0.81, P = .12). Heterogeneity was high (I2 = 74%-83%) across time points. Subgroup analyses showed no significant difference by risk of bias. PRP was well tolerated, with only isolated mild adverse events (hematoma, plaque formation) reported.
Conclusion
Current evidence does not support a consistent, clinically meaningful improvement in erectile function with PRP monotherapy compared with placebo. Despite an encouraging mechanistic rationale and safety profile, the high heterogeneity, small sample sizes, and methodological limitations of existing RCTs limit confidence in efficacy. Larger, standardized, double-blind trials with rigorous protocols are needed to clarify the role of PRP in ED management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Manchester Andrology Research Collaborative (MARC), Department of Urology, Manchester, M13 9WL, United Kingdom.
- University of California, Department of Urology, Irvine, California, 92868, United States.
ORCID-Profile: Dayan Jacob, Elia Abou Chawareb, Mohamed Mubarak
Zitieren
APA
Jacob, D., Hay, J., Rahemtoola, M. S., Sim, S., Libretto, L., Chawareb, E. A., Hammad, M., Mubarak, M., Yafi, F., Pearce, I., & Modgil, V. (2026). Current advances in platelet-rich plasma therapy for erectile dysfunction: a meta-analysis of randomized controlled trials. The Journal of Sexual Medicine, 23(1). https://doi.org/10.1093/jsxmed/qdaf325
Vancouver
Jacob D, Hay J, Rahemtoola MS, Sim S, Libretto L, Chawareb EA, et al. Current advances in platelet-rich plasma therapy for erectile dysfunction: a meta-analysis of randomized controlled trials. The Journal of Sexual Medicine. 2026;23(1). doi:10.1093/jsxmed/qdaf325
BibTeX
@article{Jacob2026,
author = {Jacob, Dayan and Hay, Jack and Rahemtoola, Muhammad Shariq and Sim, Simone and Libretto, Lois and Chawareb, Elia Abou and Hammad, Muhammed and Mubarak, Mohamed and Yafi, Faysal and Pearce, Ian and Modgil, Vaibhav},
title = {Current advances in platelet-rich plasma therapy for erectile dysfunction: a meta-analysis of randomized controlled trials},
journal = {The Journal of Sexual Medicine},
year = {2026},
volume = {23},
number = {1},
doi = {10.1093/jsxmed/qdaf325}
}
EUVIMED